EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of a Recombinant Newcastle Disease Virus Expressing H5N8 HA Against H5N1 Avian Influenza Virus (Clade 2.3.4.4b) in Broiler Chickens

Katherine Calderón, Aldo Rojas-Neyra, Brigith Carbajal-Lévano, Gloria Guerrero-Fonseca, Angela Montalván-Avalos, Doris Villanueva-Pérez, Manolo Fernández-Sánchez, Manolo Fernández-Díaz

Viruses · 18.11.2026 · 18 (11) · 1285

DOI: 10.3390/v18111285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 18.11.2026. Verfasst von Katherine Calderón und 7 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FARVET S.A.C..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Since November 2022, the highly pathogenic avian influenza (HPAI) virus subtype H5N1 clade 2.3.4.4b has caused high mortality among wild birds and poultry in Peru. Vaccines, such as recombinant Newcastle disease virus (rNDV)-vectored vaccines expressing the hemagglutinin (HA) antigen of avian influenza virus (AIV), are considered effective for preventing AI; however, the HA protein in the vaccine must be antigenically matched to the field virus to prevent mortality and virus shedding caused by AI. In this study, we developed a live rNDV-vectored vaccine expressing an HA protein with antigenic similarity to the HA of field-circulating AIV.

Methods

The rNDV rLS1 strain (the parental virus) was used as a viral vector to develop the rLS1-HAOpti vaccine (an rNDV expressing the HA protein of H5N8 clade 2.3.4.4b) through reverse genetics. The immunogenicity and efficacy of the live vaccine against an HPAI H5N1 (clade 2.3.4.4b) challenge were evaluated in broiler chickens.

Results

The vaccine induced a significant serum humoral response. After the H5N1 challenge, the vaccine provided protection and prevented virus shedding in most of the chickens.

Conclusions

The rNDV vaccine candidate provided complete protection against mortality and clinical disease in broiler chickens challenged with H5N1 under the tested experimental conditions.

Förderung

  • FARVET S.A.C.

Zitieren

APA

Calderón, K., Rojas-Neyra, A., Carbajal-Lévano, B., Guerrero-Fonseca, G., Montalván-Avalos, A., Villanueva-Pérez, D., Fernández-Sánchez, M., & Fernández-Díaz, M. (2026). Efficacy of a Recombinant Newcastle Disease Virus Expressing H5N8 HA Against H5N1 Avian Influenza Virus (Clade 2.3.4.4b) in Broiler Chickens. Viruses, 18(11), 1285. https://doi.org/10.3390/v18111285

Vancouver

Calderón K, Rojas-Neyra A, Carbajal-Lévano B, Guerrero-Fonseca G, Montalván-Avalos A, Villanueva-Pérez D, et al. Efficacy of a Recombinant Newcastle Disease Virus Expressing H5N8 HA Against H5N1 Avian Influenza Virus (Clade 2.3.4.4b) in Broiler Chickens. Viruses. 2026;18(11):1285. doi:10.3390/v18111285

BibTeX
@article{Caldern2026,
  author = {Calderón, Katherine and Rojas-Neyra, Aldo and Carbajal-Lévano, Brigith and Guerrero-Fonseca, Gloria and Montalván-Avalos, Angela and Villanueva-Pérez, Doris and Fernández-Sánchez, Manolo and Fernández-Díaz, Manolo},
  title = {Efficacy of a Recombinant Newcastle Disease Virus Expressing H5N8 HA Against H5N1 Avian Influenza Virus (Clade 2.3.4.4b) in Broiler Chickens},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1285},
  doi = {10.3390/v18111285}
}
Kostenlos starten →